Difference between revisions of "Part:BBa K1537016"
(→Characterization done by SUSTech_Shenzhen 2019) |
Ahmed Wael (Talk | contribs) |
||
(4 intermediate revisions by one other user not shown) | |||
Line 8: | Line 8: | ||
2A peptide sequences were found in Picornaviruses to mediate "cleavage" between two proteins. We use 2A peptide-linked | 2A peptide sequences were found in Picornaviruses to mediate "cleavage" between two proteins. We use 2A peptide-linked | ||
multicistronic vectors to express multiple proteins from a single open reading frame (ORF) effectively. To minimize the risk of homologous recombination, it is important to use different 2A peptide sequences if more than two genes are being linked. The 2A peptide system has thus far worked successfully in all eukaryotic systems tested, from mammalian cells, yeast, and plants.(A El et al,2004)[[File:abc.jpg]] | multicistronic vectors to express multiple proteins from a single open reading frame (ORF) effectively. To minimize the risk of homologous recombination, it is important to use different 2A peptide sequences if more than two genes are being linked. The 2A peptide system has thus far worked successfully in all eukaryotic systems tested, from mammalian cells, yeast, and plants.(A El et al,2004)[[File:abc.jpg]] | ||
− | |||
== '''GSG linker''' == | == '''GSG linker''' == | ||
GSG linker is an oligopeptide of “Gly-Ser-Gly” between your protein and 2A peptide to enhance cleavage.( Andrea L et al,2012) | GSG linker is an oligopeptide of “Gly-Ser-Gly” between your protein and 2A peptide to enhance cleavage.( Andrea L et al,2012) | ||
− | + | == '''Improvements by AFCM-EGYPT 2020''' == | |
+ | Team:<html><a href="https://2020.igem.org/Team:AFCM-Egypt">AFCM-Egypt 2020</a></html>has improved this part by inserting V5 epitope tag (GKPUPNPLLGLDST) and 3xFlag epitope tag immediately preceding 2A which has been shown to improve 2A cleavage efficiency. and provided characterization from literature that P2A has superior cleavage ability over other 2A peptides all of which is presented in the following part <html><a href="https://parts.igem.org/Part:BBa_K3504018">BBa_K3504018</a></html> | ||
+ | [[Image:P2A_Sbol.png|thumb|Right|Figure 2. P2A+GSG enhancement using V5 epitope tag (GKPUPNPLLGLDST) and 3xFlag epitope tag.]] | ||
+ | [[Image:P2A_Characterization.jpg|thumb|left|Figure 1. Comparison of different 2A peptides according to trastuzumab expression.]]<br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /> | ||
=='''Characterization done by SUSTech_Shenzhen 2019'''== | =='''Characterization done by SUSTech_Shenzhen 2019'''== | ||
Line 53: | Line 55: | ||
<td> | <td> | ||
<figure> | <figure> | ||
− | <img src="https://2019.igem.org/wiki/images/c/c4/T--SUSTech_Shenzhen--p2Afigure.png" alt="Figure 4: Comparison of eGFP expression level of two cell lines="width:100%;" /> | + | <img src="https://2019.igem.org/wiki/images/c/c4/T--SUSTech_Shenzhen--p2Afigure.png" alt="Figure 4: Comparison of eGFP expression level of two cell lines (with our without 2A sequence)"style="width:100%;" /> |
− | <figcaption> | + | <figcaption>Figure 4: Comparison of eGFP expression level of two cell lines (with our without 2A sequence)</figcaption> |
</figure> | </figure> | ||
</td> | </td> | ||
Line 66: | Line 68: | ||
<figure> | <figure> | ||
<img src="https://2019.igem.org/wiki/images/8/87/T--SUSTech_Shenzhen--p2AELISA-1.jpeg" alt="Figure 5: IL10 ELISA test" style="width:72%;" /> | <img src="https://2019.igem.org/wiki/images/8/87/T--SUSTech_Shenzhen--p2AELISA-1.jpeg" alt="Figure 5: IL10 ELISA test" style="width:72%;" /> | ||
− | <figcaption> | + | <figcaption>Figure 5: IL10 ELISA test</figcaption> |
</figure> | </figure> | ||
</td> | </td> | ||
Line 72: | Line 74: | ||
<figure> | <figure> | ||
<img src="https://2019.igem.org/wiki/images/c/c4/T--SUSTech_Shenzhen--p2AELISA-2.jpg" alt="Figure 6: Result of IL10 ELISA test" style="width:100%;" /> | <img src="https://2019.igem.org/wiki/images/c/c4/T--SUSTech_Shenzhen--p2AELISA-2.jpg" alt="Figure 6: Result of IL10 ELISA test" style="width:100%;" /> | ||
− | <figcaption> | + | <figcaption>Figure 6: Result of IL10 ELISA test</figcaption> |
</figure> | </figure> | ||
</td> | </td> | ||
</tr> | </tr> | ||
</table> | </table> | ||
+ | |||
+ | |||
</html> | </html> | ||
+ | |||
Latest revision as of 14:21, 20 October 2020
GSG linker+P2A
P2A
2A peptide sequences were found in Picornaviruses to mediate "cleavage" between two proteins. We use 2A peptide-linked multicistronic vectors to express multiple proteins from a single open reading frame (ORF) effectively. To minimize the risk of homologous recombination, it is important to use different 2A peptide sequences if more than two genes are being linked. The 2A peptide system has thus far worked successfully in all eukaryotic systems tested, from mammalian cells, yeast, and plants.(A El et al,2004)
GSG linker
GSG linker is an oligopeptide of “Gly-Ser-Gly” between your protein and 2A peptide to enhance cleavage.( Andrea L et al,2012)
Improvements by AFCM-EGYPT 2020
Team:AFCM-Egypt 2020has improved this part by inserting V5 epitope tag (GKPUPNPLLGLDST) and 3xFlag epitope tag immediately preceding 2A which has been shown to improve 2A cleavage efficiency. and provided characterization from literature that P2A has superior cleavage ability over other 2A peptides all of which is presented in the following part BBa_K3504018
Characterization done by SUSTech_Shenzhen 2019
SUSTech_Shenzhen 2019 iGEM team improved the characterization of this part by linked the 2A sequence with two target protein (cytokine IL-10 and eGFP, enhanced green fluorescent protein) and measured the expression level of the desired protein. By the measurement data, we conformed the feasibility of 2A peptide in a new chassis (HeLa cell). We also provided quantitative data to analyze the influence of 2A's cleavage function on the expression level of downstream protein.
First, we obtained the DNA sequence of 2A peptide from 2019 iGEM distribution and linked our target protein sequence to construct two plasmid: 5xUAS-EGFP and 5xUAS-IL10-2A-EGFP, 5xUAS is the binding site of part BBa_K2986003(GAVPO, a light-switchable trans activator). (figure1-2: plasmid construction)
From figure 3-6, we conformed that this part is functional in HeLa cell line: the IL-10 and eGFP is cleaved by 2A peptide and successfully expressed. Our quantitative data from figure 3-4 also provided another characterization feature of 2A peptide: expression level of the latter protein linked after 2A (eGFP level in the IL10-2A-eGFP cell line) is lower than the control group without 2A (eGFP cell line). The eGFP expression level after 2A is decreased 29.64%.
References
Abdelhak El Amrani,Abdellah Barakate,Barak M. Askari, Xuejun Li, Alison G. Roberts,Martin D. Ryan, and Claire Halpin.(2004)Coordinate Expression and Independent Subcellular Targeting of Multiple Proteins from a Single Transgene.Plant Physiology.Vol. 135, pp. 16–24
Andrea L. Szymczak-Workman, Kate M. Vignali, and Dario A.A. Vignali.(2012)Design and construction of 2A vectors.Cold Spring Harb Protoc :199-204.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]